Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction

authors:

avatar Gian Paolo Caviglia 1 , * , avatar Rinaldo Pellicano 2

Department of Medical Sciences, University of Turin, Turin, Italy
Department of Gastroenterology, Citta della Salute e della Scienza, Molinette Hospital, Turin, Italy
Hepatitis Monthly: Vol.15, issue 8; e30853
published online: August 17, 2015
article type: Letter
received: June 17, 2015
accepted: July 4, 2015
DOI: https://doi.org/10.5812/hepatmon.30853

how to cite: Caviglia G P, Pellicano R. Serum Cytokeratin-18 Levels for Liver Fibrosis Prediction. Hepat Mon. 2015;15(8):e30853. https://doi.org/10.5812/hepatmon.30853.

References

  • 1.

    Yang ZH, Yang SX, Qin CZ, Chen YX. Clinical values of elevated serum cytokeratin-18 levels in hepatitis: a meta-analysis. Hepat Mon. 2015;15(5). ee25328. [PubMed ID: 26045704]. https://doi.org/10.5812/hepatmon.15(5)2015.25328.

  • 2.

    Caviglia GP, Ciancio A, Rosso C, Abate ML, Olivero A, Pellicano R, et al. Non-invasive methods for the assessment of hepatic fibrosis: transient elastography, hyaluronic acid, 13C-aminopyrine breath test and cytokeratin 18 fragment. Ann Hepatol. 2013;13(1):91-7. [PubMed ID: 24378271].

  • 3.

    Papatheodoridis GV, Hadziyannis E, Tsochatzis E, Chrysanthos N, Georgiou A, Kafiri G, et al. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection. Gut. 2008;57(4):500-6. [PubMed ID: 18025069]. https://doi.org/10.1136/gut.2007.123943.

  • 4.

    Eguchi A, Wree A, Feldstein AE. Biomarkers of liver cell death. J Hepatol. 2014;60(5):1063-74. [PubMed ID: 24412608]. https://doi.org/10.1016/j.jhep.2013.12.026.

  • 5.

    Cusi K, Chang Z, Harrison S, Lomonaco R, Bril F, Orsak B, et al. Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease. J Hepatol. 2014;60(1):167-74. [PubMed ID: 23973932]. https://doi.org/10.1016/j.jhep.2013.07.042.